Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients—A retrospective analysis of a single medical center in Taiwan-Reference-Cited by-同舟云学术

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients—A retrospective analysis of a single medical center in Taiwan

Published:2016-08 Issue:4 Volume:49 Page:531-538
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Wang Ching-Hsun,Kan Li-Ping,Lin Hsin-An,Chang Feng-Yee,Wang Ning-Chi,Lin Te-Yu,Chao Tsu-Yi,Kao Woei-Yau,Ho Ching-Liang,Chen Yeu-Chin,Dai Ming-Shen,Chang Ping-Ying,Wu Yi-Ying,Lin Jung-Chung

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference23 articles.

1. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients;Barnes;Br J Haematol,2007

2. Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience;Zhang;Transpl Infect Dis,2010

3. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective;Tomblyn;Bone Marrow Transplant,2009

4. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3–2009 update;Maertens;Bone Marrow Transplant,2011

5. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients;Almyroudis;Expert Rev Anti Infect Ther,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Posaconazole Serum Concentrations Achieved With Delayed-release Tablets and Oral Suspension in Patients Undergoing Intensive Chemotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome;Open Forum Infectious Diseases;2024-04-26

2. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation;Expert Review of Hematology;2023-12-02

3. Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches;Transplant Infectious Disease;2022-11-15

4. Efficacy and Safety of Caspofungin in Primary Prophylaxis of Invasive Fungal Disease in Patients with Hematopoietic Stem Cell Transplantation;Advances in Clinical Medicine;2022

5. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021;Internal Medicine Journal;2021-11